LONDON, July 25 (Reuters) - The European Medicines Agency has recommended extended use of Takeda Pharmaceutical Co and Johnson & Johnson’s cancer drug Velcade for certain people with previously untreated multiple myeloma, the London-based watchdog said on Friday.
